Evidence map›Paper›PMID 21360282›Full record

ArticleMolecular and cellular biochemistry2011

DUSP13B/TMDP inhibits stress-activated MAPKs and suppresses AP-1-dependent gene expression.

Chiaki Katagiri, Kouhei Masuda, Miyuki Nomura, Kan Tanoue, Shoko Fujita, Yoji Yamashita, Ryuichi Katakura, Ken-ichi Shiiba, Eiki Nomura, Masami Sato and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Chiaki KatagiriDivision of Cancer Chemotherapy, Miyagi Cancer Center Research Institute, Medeshima-Shiode, Natori, Japan.
Kouhei Masuda
Miyuki Nomura
Kan Tanoue
Shoko Fujita
Yoji Yamashita
Ryuichi Katakura
Ken-ichi Shiiba
Eiki Nomura
Masami Sato
Nobuhiro Tanuma
Hiroshi Shima
Miyagi Prefectural Hospital Organization · JPHokkaido University · JPTochigi Cancer Center · JPTohoku University · JPUniversity of the Ryukyus University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The dual-specificity phosphatase (DUSP) 13 gene encodes two atypical DUSPs, DUSP13B/TMDP and DUSP13A/MDSP using alternative exons. DUSP13B protein is most highly expressed in testis, particularly in spermatocytes and round spermatids of the seminiferous tubules, while that of DUSP13A is restricted to skeletal muscle. Here, we show that DUSP13B inactivated MAPK activation in the order of selectivity, JNK = p38>ERK in cells, while DUSP13A did not show MAPK phosphatase activity. Reporter gene analysis showed that DUSP13B had significant inhibitory effect on AP-1-dependent gene expression, but DUSP13A did not. To our knowledge, DUSP13B is the first identified testis-specific phosphatase that inhibits stress-activated MAPKs. These data suggest an important role for DUSP13B in protection from external stress during spermatogenesis.

Indexed as

AnimalsCell LineDual-Specificity PhosphatasesEnzyme ActivationExonsGene Expression RegulationHumansMitogen-Activated Protein KinasesProtein Kinase InhibitorsTranscription Factor AP-1Dual-Specificity PhosphatasesDUSP13B protein, humanMitogen-Activated Protein KinasesProtein Kinase InhibitorsTranscription Factor AP-1

Identifiers

PMID21360282
OpenAlexW2017694878

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.